Vittorio Montefusco

5.5k total citations
90 papers, 1.6k citations indexed

About

Vittorio Montefusco is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Vittorio Montefusco has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Hematology, 41 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Vittorio Montefusco's work include Multiple Myeloma Research and Treatments (63 papers), Cancer Treatment and Pharmacology (25 papers) and Protein Degradation and Inhibitors (18 papers). Vittorio Montefusco is often cited by papers focused on Multiple Myeloma Research and Treatments (63 papers), Cancer Treatment and Pharmacology (25 papers) and Protein Degradation and Inhibitors (18 papers). Vittorio Montefusco collaborates with scholars based in Italy, Netherlands and Germany. Vittorio Montefusco's co-authors include Paolo Corradini, Mario Boccadoro, Antonio Palumbo, Giovanni Martinelli, Carolina Terragna, Francesca Patriarca, Francesca Gay, S Tura, Francesco Spina and Lucia Farina and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vittorio Montefusco

89 papers receiving 1.6k citations

Peers

Countries citing papers authored by Vittorio Montefusco

Since Specialization

Citations

This map shows the geographic impact of Vittorio Montefusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittorio Montefusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittorio Montefusco more than expected).

Fields of papers citing papers by Vittorio Montefusco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vittorio Montefusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittorio Montefusco. The network helps show where Vittorio Montefusco may publish in the future.

Co-authorship network of co-authors of Vittorio Montefusco

This figure shows the co-authorship network connecting the top 25 collaborators of Vittorio Montefusco. A scholar is included among the top collaborators of Vittorio Montefusco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittorio Montefusco. Vittorio Montefusco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experts’ consensus on the definition and management of high risk multiple myeloma 2023 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Alessandro Corso, Daniele Derudas, Vittorio Montefusco, Massimo Offidani, Maria Teresa Petrucci, Renato Zambello, Raffaella Stocchi, Renato Fanin, Francesca Patriarca	15
2	Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma 2020 ·Blood Advances ·Bachisio Ziccheddu, Giulia Biancon, (unknown), Chiara De Philippis, Francesco Maura, Even H Rustad, Matteo Dugo, (unknown), Loris De Cecco, Marialuisa Sensi, Carolina Terragna, Marina Martello, Tina Bagratuni, Efstathios Kastritis, Meletios Α. Dimopoulos, Michèle Cavo, Cristiana Carniti, Vittorio Montefusco, Paolo Corradini, Niccolò Bolli	49
3	Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure 2020 ·Journal of Clinical Medicine ·Alberto Mussetti, María Queralt Salas, Vittorio Montefusco	2
4	Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse 2020 ·British Journal of Haematology ·Vittorio Montefusco, Alessandro Corso, Mónica Galli, (unknown), Sara Pezzatti, (unknown), Francesca Patriarca, Filíppo Gherlinzoni, Renato Zambello, Simona Sammassimo, Magda Marcatti, Andrea Nozza, Claudia Crippa, Anna Maria Cafro, Luca Baldini, Paolo Corradini	7
5	How I Manage Frontline Transplant-Eligible Multiple Myeloma in Italy 2020 ·SHILAP Revista de lepidopterología ·Vittorio Montefusco, Giovanni Martinelli, Claudio Cerchione	1
6	PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression 2019 ·Annals of Hematology ·Alberto Mussetti, Alessio Pellegrinelli, Nicoletta Cieri, (unknown), (unknown), Antonello D. Cabras, Vittorio Montefusco	17
7	Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies 2019 ·Haematologica ·Sara Bringhen, Roberto Mina, Maria Teresa Petrucci, Gianluca Gaïdano, Stelvio Ballanti, Pellegrino Musto, Massimo Offidani, Stefano Spada, Giulia Benevolo, (unknown), Piero Galieni, Michèle Cavo, Tommaso Caravita di Toritto, Francesco Di Raimondo, Vittorio Montefusco, Antonio Palumbo, Mario Boccadoro, Alessandra Larocca	19
8	Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis 2017 ·Biology of Blood and Marrow Transplantation ·Luca Castagna, Alberto Mussetti, Raynier Devillier, Alida Dominietto, Magda Marcatti, Giuseppe Milone, Francesco Maura, Chiara De Philippis, Benedetto Bruno, Sabine Fürst, Didier Blaise, Paolo Corradini, Vittorio Montefusco	23
9	Next‐generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles 2017 ·Cancer ·Niccolò Bolli, Matteo Barcella, Erika Salvi, Francesca D’Avila, Antonio Vendramin, Chiara De Philippis, Nikhil C. Munshi, Hervé Avet‐Loiseau, Peter J. Campbell, Alberto Mussetti, Cristiana Carniti, Francesco Maura, Cristina Barlassina, Paolo Corradini, Vittorio Montefusco	15
10	Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients 2017 ·Bone Marrow Transplantation ·Vittorio Montefusco, Alberto Mussetti, (unknown), Francesco Maura, Martina Pennisi, Chiara De Philippis, Marco Capecchi, Paolo Corradini	14
11	Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma 2017 ·Leukemia ·Sara Bringhen, Mattia D’Agostino, Lorenzo De Paoli, Vittorio Montefusco, Anna Marina Liberati, Piero Galieni, Sara Grammatico, (unknown), (unknown), Carmine De Angelis, Pellegrino Musto, Stelvio Ballanti, (unknown), Martina Petrucci, Gianluca Gaïdano, Paolo Corradini, Antonio Palumbo, Pieter Sonneveld, Mario Boccadoro	17
12	Are maintenance and continuous therapies indicated for every patient with multiple myeloma? 2016 ·Expert Review of Hematology ·Pellegrino Musto, Vittorio Montefusco	11
13	Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation 2014 ·Biology of Blood and Marrow Transplantation ·Jacopo Mariotti, Francesco Maura, Francesco Spina, (unknown), Anna Dodero, Lucia Farina, Vittorio Montefusco, Cristiana Carniti, Barbara Sarina, Francesca Patriarca, Alessandro Rambaldi, Francesco Onida, Attilio Olivieri, Francesco Zallio, Paolo Corradini	32
14	Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study 2013 ·Blood ·Alessandra Larocca, Vittorio Montefusco, Sara Bringhen, Davide Rossi, Claudia Crippa, Roberto Mina, Mónica Galli, Magda Marcatti, Giacinto La Verde, Nicola Giuliani, Valeria Magarotto, Tommasina Guglielmelli, Delia Rota‐Scalabrini, Paola Omedè, Alberto Santagostino, Ileana Baldi, Angelo Michele Carella, Mario Boccadoro, Paolo Corradini, Antonio Palumbo	66
15	Superior Outcomes With Bortezomib Or Thalidomide Incorporated Into Autologous Stem Cell Transplantation (ASCT) Versus Novel Agent-Based Treatments For Elderly Patients With Newly Diagnosed Multiple Myeloma (MM): A Case-Match Comparison 2013 ·Blood ·Sara Bringhen, Lucia Pantani, Annalisa Pezzi, Beatrice Anna Zannetti, Paola Tacchetti, Patrizia Tosi, Alessandra Larocca, Katia Mancuso, Francesca Patriarca, Serena Rocchi, Nicoletta Testoni, Vittorio Montefusco, Barbara Gamberi, Annamaria Brioli, Giulia Marzocchi, Carolina Terragna, Antonio Palumbo, Michèle Cavo	1
16	Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor 2013 ·Leukemia & lymphoma ·Lucia Farina, Francesco Spina, Anna Guidetti, Paolo Longoni, Fernando Ravagnani, Anna Dodero, Vittorio Montefusco, Carmelo Carlo‐Stella, Paolo Corradini	20
17	Response‐adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression‐free survival in transplanted patients with multiple myeloma 2011 ·American Journal of Hematology ·Alessandro Corso, Mónica Galli, Silvia Mangiacavalli, Fausto Rossini, Andrea Nozza, Cristiana Pascutto, Vittorio Montefusco, Luca Baldini, Anna Maria Cafro, Claudia Crippa, (unknown), Paolo Corradini	8
18	Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates 2008 ·Leukemia & lymphoma ·Vittorio Montefusco, Francesca Gay, Francesco Spina, Rosalba Miceli, Massimo Maniezzo, Maria Teresa Ambrosini, Lucia Farina, Sheila Piva, Antonio Palumbo, Mario Boccadoro, Paolo Corradini	111
19	Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. 2001 ·PubMed ·Marilina Amabile, Barbara Giannini, Nicoletta Testoni, Vittorio Montefusco, Gianantonio Rosti, (unknown), Carolina Terragna, Silvia Buonamici, Emanuela Ottaviani, Simona Soverini, Mauro Fiacchini, Sebastián Bassi, Antonio De Vivo, Elena Trabacchi, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, S Tura, Giovanni Martinelli	36
20	Real-time quantification of different types of BcrAbl transcript in chronic myeloid leukemia 2000 ·Blood ·Barbara Giannini, Vittorio Montefusco, (unknown), Nicoletta Testoni, (unknown), Carolina Terragna, Silvia Buonamici, Emanuela Ottaviani, Simona Bassi, (unknown), Michele Baccarani, Giuseppe Saglio, S Tura	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact